Literature DB >> 29470653

[Lymph-node-positive penile cancer : Management and systemic therapy].

A Aziz1, S Milerski2, K Kernig2, C Protzel3, O W Hakenberg2.   

Abstract

Cancer-specific survival in men with penile cancer depends foremost on regional lymphatic metastasis and its extent. Patients with limited inguinal lymph node metastases have a 5-year survival of up to 80%. However, those with pelvic lymph node metastases and/or systemic disease have a 5-year survival prognosis of only 0-33%. In any case, in patients with regional lymph node metastases multimodal treatment with complete lymphadenectomy and adjuvant chemotherapy is indicated.

Entities:  

Keywords:  Adjuvant chemotherapy; Lymph node; Lymph node biopsy; Lymphadenectomy; Metastasis; Penile cancer; Radiotherapy

Mesh：

Year:  2018        PMID： 29470653     DOI： 10.1007/s00120-018-0601-y

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  30 in total

1.  Radical excision of the inguinal and iliac lymph glands; a study based upon 450 anatomical dissections and upon supportive clinical observations.

Authors:  E H DASELER; B J ANSON; A F REIMANN
Journal:  Surg Gynecol Obstet       Date:  1948-12

2.  Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis.

Authors:  G Pizzocaro; L Piva
Journal:  Acta Oncol       Date:  1988       Impact factor: 4.089

3.  Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study.

Authors:  G P Haas; B A Blumenstein; R G Gagliano; C A Russell; S E Rivkin; D J Culkin; M Wolf; E D Crawford
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450

4.  Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma.

Authors:  Carlos Bermejo; J Erik Busby; Philippe E Spiess; Lior Heller; Lance C Pagliaro; Curtis A Pettaway
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

5.  Video endoscopic inguinal lymphadenectomy: a new minimally invasive procedure for radical management of inguinal nodes in patients with penile squamous cell carcinoma.

Authors:  Marcos Tobias-Machado; Alessandro Tavares; Antônio Augusto Ornellas; Wilson Rica Molina; Roberto Vaz Juliano; Eric Roger Wroclawski
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

6.  Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas.

Authors:  A M Hussein; P Benedetto; K S Sridhar
Journal:  Cancer       Date:  1990-02-01       Impact factor: 6.860

7.  Cisplatin and 5-fluorouracil in advanced cancer of the penis.

Authors:  F V Shammas; S Ous; S D Fossa
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

Review 8.  Lymphadenectomy in the surgical management of penile cancer.

Authors:  Chris Protzel; Antonio Alcaraz; Simon Horenblas; Giorgio Pizzocaro; Alexandre Zlotta; Oliver W Hakenberg
Journal:  Eur Urol       Date:  2009-02-23       Impact factor: 20.096

9.  Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma.

Authors:  Surena F Matin; Janice N Cormier; John F Ward; Louis L Pisters; Christopher G Wood; Colin P N Dinney; Richard E Royal; Xuelin Huang; Curtis A Pettaway
Journal:  BJU Int       Date:  2013-04-02       Impact factor: 5.588

10.  Penile cancer: relation of extent of nodal metastasis to survival.

Authors:  V Srinivas; M J Morse; H W Herr; P C Sogani; W F Whitmore
Journal:  J Urol       Date:  1987-05       Impact factor: 7.450
View more
  1 in total

1.  Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS).

Authors:  Steffen Lebentrau; Gamal Anton Wakileh; Martin Schostak; Hans-Peter Schmid; Rodrigo Suarez-Ibarrola; Axel S Merseburger; Georg C Hutterer; Ulrike H Necknig; Michael Rink; Martin Bögemann; Luis Alex Kluth; Armin Pycha; Maximilian Burger; Sabine D Brookman-May; Johannes Bründl; Matthias May
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.